J8611 – Methotrexate (jylamvo), oral, 2.5 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ8611
- Long description
- Methotrexate (jylamvo), oral, 2.5 mg
- Short description
- Oral methotrexate (jylamvo)
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J8611?
J8611 is a HCPCS Level II code for methotrexate (jylamvo), oral, 2.5 mg.
Does Medicare cover J8611?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J8540 – Dexamethasone, oral, 0.25 mg
- J8541 – Dexamethasone (hemady), oral, 0.25 mg
- J8560 – Etoposide; oral, 50 mg
- J8562 – Fludarabine phosphate, oral, 10 mg
- J8565 – Gefitinib, oral, 250 mg
- J8597 – Antiemetic drug, oral, not otherwise specified
- J8600 – Melphalan; oral, 2 mg
- J8610 – Methotrexate; oral, 2.5 mg
- J8612 – Methotrexate (xatmep), oral, 2.5 mg
- J8650 – Nabilone, oral, 1 mg
- J8655 – Netupitant 300 mg and palonosetron 0.5 mg, oral
- J8670 – Rolapitant, oral, 1 mg
- J8700 – Temozolomide, oral, 5 mg
- J8705 – Topotecan, oral, 0.25 mg
- J8999 – Prescription drug, oral, chemotherapeutic, nos
- J9000 – Injection, doxorubicin hydrochloride, 10 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.